Ads
related to: plaque psoriasis treatment- Treatment Option
Get Info On Treatment
Option. Learn More Today.
- Save on Prescription
Savings Program
2023 Program Requirements Apply.
- Treatment Support
See Treatment Support Resources For
Questions About Costs, Dosing, etc.
- Insurance Coverage
Learn About Insurance Coverage &
Patient Support.
- Dosing Timeline
Learn About a Dosing Schedule
and Administration Options.
- Get Personalized Emails
Complete Form to Receive
Personalized Resources.
- Treatment Option
Search results
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 3 days agoWith two kids under 2, I needed some relief. I had been through enough psoriasis treatment and had...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days ago"Zai Lab doses first subject in Phase II plaque psoriasis treatment trial" was originally created...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 3 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 4 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Ultravate side effects: What they are and how to manage them
Healthline· 5 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to ...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 4 days agoThe board will seek public comments, additional information and data over the next 60 days to...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 5 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 3 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
WKRN Nashville· 2 days agoIn these studies, bimekizumab consistently demonstrated sustained improvements...